1. Home
  2. KLTOW vs TRNR Comparison

KLTOW vs TRNR Comparison

Compare KLTOW & TRNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KLTOW
  • TRNR
  • Stock Information
  • Founded
  • KLTOW N/A
  • TRNR 2017
  • Country
  • KLTOW United States
  • TRNR United States
  • Employees
  • KLTOW 3
  • TRNR N/A
  • Industry
  • KLTOW Biotechnology: Biological Products (No Diagnostic Substances)
  • TRNR Consumer Electronics/Appliances
  • Sector
  • KLTOW Health Care
  • TRNR Technology
  • Exchange
  • KLTOW Nasdaq
  • TRNR Nasdaq
  • Market Cap
  • KLTOW N/A
  • TRNR 6.8M
  • IPO Year
  • KLTOW 2022
  • TRNR 2023
  • Fundamental
  • Price
  • KLTOW $0.26
  • TRNR $6.63
  • Analyst Decision
  • KLTOW
  • TRNR
  • Analyst Count
  • KLTOW 0
  • TRNR 0
  • Target Price
  • KLTOW N/A
  • TRNR N/A
  • AVG Volume (30 Days)
  • KLTOW N/A
  • TRNR 1.1M
  • Earning Date
  • KLTOW N/A
  • TRNR 08-13-2025
  • Dividend Yield
  • KLTOW N/A
  • TRNR N/A
  • EPS Growth
  • KLTOW N/A
  • TRNR N/A
  • EPS
  • KLTOW N/A
  • TRNR N/A
  • Revenue
  • KLTOW N/A
  • TRNR $6,373,000.00
  • Revenue This Year
  • KLTOW N/A
  • TRNR $355.02
  • Revenue Next Year
  • KLTOW N/A
  • TRNR N/A
  • P/E Ratio
  • KLTOW N/A
  • TRNR N/A
  • Revenue Growth
  • KLTOW N/A
  • TRNR 445.63
  • 52 Week Low
  • KLTOW N/A
  • TRNR $3.74
  • 52 Week High
  • KLTOW N/A
  • TRNR $1,370.00
  • Technical
  • Relative Strength Index (RSI)
  • KLTOW N/A
  • TRNR 49.03
  • Support Level
  • KLTOW N/A
  • TRNR $3.74
  • Resistance Level
  • KLTOW N/A
  • TRNR $7.08
  • Average True Range (ATR)
  • KLTOW 0.00
  • TRNR 0.89
  • MACD
  • KLTOW 0.00
  • TRNR 0.14
  • Stochastic Oscillator
  • KLTOW 0.00
  • TRNR 82.34

About KLTOW Klotho Neurosciences Inc. Warrant

Klotho Neurosciences Inc is in the development of essential medicines for the treatment of chronic diseases: Cancer, Cardiovascular, and Neurodegenerative disorders. The Company currently has acquired two licensed platforms: a generic drug portfolio and a biosimilar biologics platform that uses biologic therapies to treat cancer, and a proprietary, patented gene therapy platform which uses a gene therapy approach to introduce a therapeutic protein called Klotho inside the body to treat neurodegenerative diseases. Company pipeline includes KLTO 101, KLTO 202, KLTO 301.

About TRNR Interactive Strength Inc.

Interactive Strength Inc provides an integrated home fitness platform that allows its customers to participate in interactive wellness and strength-based training sessions. Its health coaching services encompass guidance and coaching on nutrition, recovery, sleep, and other health and lifestyle categories. The company generates revenue from sales of its connected fitness products, membership revenue, and personal training revenue.

Share on Social Networks: